Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies [Phase 2]
A Phase 2 study of non-Myeloablative HLA-matched ex-vivo T-cell depleted stem cell transplantation for hematologic malignancies was terminat…
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia [Phase 2]
This document reports the completion of a Phase II clinical trial evaluating perifosine in patients with refractory or relapsed leukemia.
-
CLINICAL_TRIALS trial_result · 2018-01-29Clinical Trial Update: Paricalcitol in Treating Patients With Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating paricalcitol in patients with myelodysplastic syndrome; study completed.
-
CLINICAL_TRIALS trial_result · 2018-01-12Clinical Trial Update: A Feasibility Study of Prophylactic White Blood Cell Transfusions [Phase 2]
Phase 2 feasibility study evaluating prophylactic white blood cell transfusions in leukemia patients has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS [Phase 2]
Phase 2 trial update of azacitidine plus lenalidomide in elderly patients with previously treated acute myeloid leukemia and high-risk myelo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating the safety and potential antitumor effects of atorvastatin in Non-Hodgkin lymphoma; study completed with results po…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma [Phase 1]
Phase 1 clinical trial update for DT2219ARL in relapsed or refractory CD19+/CD22+ B-lineage leukemia or lymphoma.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases [Phase 1]
Phase 1 trial evaluating the safety of Umbilical Cord Blood T-Regulatory Cell infusion followed by donor cord blood transplant in patients w…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating infusion of regulatory T cells after umbilical cord blood transplant in patients with advanced hematologic…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer [Phase 1, Phase 2]
A Phase 1/2 trial update on using combination chemotherapy and total-body irradiation before donor umbilical cord blood transplant in patien…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 1]
A Phase 1 trial evaluating donor T cells in high-risk hematologic cancers undergoing donor peripheral blood stem cell transplant was termina…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant [Phase 1]
A Phase 1 trial assessing CpG 7909 in patients who have undergone autologous stem cell transplant has been terminated. The study included pa…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [NA]
ClinicalTrials.gov entry describes termination of a study evaluating donor umbilical cord blood transplantation for various hematologic canc…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia [Phase 1]
The update reports termination of a Phase 1 trial evaluating AHN-12, a Yttrium-90 labeled anti-CD45 monoclonal antibody, in advanced leukemi…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer [NA]
This clinical trial update reports completion of a study evaluating chemotherapy and total-body irradiation followed by donor umbilical cord…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors [NA]
The document reports a completed University of North Carolina clinical trial studying survivorship and psychological outcomes in bone marrow…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Chinese Herbal Medicine for Immune Reconstitution Following HSCT in Acute Leukemia Patients [NA]
A completed clinical trial evaluated Chinese herbal medicine for immune reconstitution after hematopoietic stem cell transplantation in pati…
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer [Phase 1]
Phase 1 study evaluating low-dose fludarabine, busulfan, and anti-thymocyte globulin conditioning followed by donor umbilical cord blood tra…
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies [Phase 2]
Phase 2 clinical trial update on allogeneic transplantation using total lymphoid irradiation and anti-thymocyte globulin in older patients w…
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
Phase I/II trial of Brentuximab in combination with 5-azacytidine for leukemia was terminated; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating chemotherapy followed by unrelated donor stem cell transplantation for blood and immune system cancers; …
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 study of oral LBH589 (panobinostat) in adults with advanced hematologic malignancies completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL) [Phase 1]
Phase 1 trial evaluating CD19-specific T-cell therapy for Chronic Lymphocytic Leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells [Phase 1]
A Phase 1 study evaluating infusion of allogeneic cord blood-derived CD19-specific T cells for leukemia and lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma [Phase 1]
Phase 1 trial of Recombinant Human Arginase 1 (rhArg1) in relapsed or refractory leukemia or lymphoma has been terminated. This status updat…